We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Verathon

Verathon is a global medical device company that provides products and technologies for bladder volume measurement an... read more Featured Products: More products

Download Mobile App




Portable Ultrasound Device Quantifies Bladder Volume

By HospiMedica International staff writers
Posted on 08 Feb 2016
A new portable three-dimensional (3D) ultrasound instrument helps reduce catheter-associated urinary tract infections (CAUTI) by reducing the use of catheters.

The Verathon BladderScan Prime is a noninvasive bladder volume measurement tool that acquires multiple scan planes inside the body, produces 3D quantification of the bladder, and then automatically calculates and displays urinary bladder volume. More...
To boost reading accuracy among users of varying skill levels, the device provides simple and advanced aiming modes; immediate feedback for off-center scans and pubic bone interference; and onboard help and tutorial assistance accessible at any point during the exam.

Features of the system include a touch-screen interface, live B-mode scanning, and onboard self-diagnostics; for example, in the event of a drop, the ultrasound probe has an internal mechanical diagnostic to confirm it is still functioning properly. Benefits of the system include reducing unnecessary catheterizations; management of Foley catheter use and incontinence issues; and reducing costs and nursing staff time. The Verathon BladderScan Prime is a product of Verathon (Bothell, WA, USA).

“Prime is built to be a workhorse device in any healthcare environment. It is designed to reduce downtime, which in turn raises quality of care,” said David Garner, global director of marketing for imaging & scanning solutions at Verathon. “Prime is designed to help reduce catheter associated urinary tract infections, one of the leading causes of infection in hospitals today, and despite years of efforts, those infection rates aren't improving. We're hoping to change that.”

Bladder volume measurement is a well-established metric used in the diagnosis and treatment of a wide range of medical conditions. It is a critical component of a comprehensive catheter-associated urinary tract infections (CAUTI) prevention program, an area of intense focus for hospitals as a result of Medicare penalties for hospitals with high rates. These include reducing payments by one percent for hospitals with a high number of hospital acquired conditions (HACs).

Related Links:

Verathon



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.